Author:
Chen Liqi,Li Guoli,Li Jieshou,Fan Chaogang,Xu Jian,Wu Bo,Liu Kun,Zhang Caihua
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference23 articles.
1. Yang L (2006) Incidence and mortality of gastric cancer in China. World J Gastroenterol 12(1):17–20
2. Chua YJ, Cunningham D (2007) The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice. Ann Surg Oncol 14(10):2687–2690. doi: 10.1245/s10434-007-9423-7
3. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, Participants MT (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20. doi: 10.1056/NEJMoa055531
4. Li G-L, Bao Y, Jiang J, Fan C-G, Wang Z-M, Li N, Li J-S (2008) Arteriovenous neoadjuvant FLEOX chemotherapy with nutritional support improves the resectable rate for advanced gastric cancer. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery (5)
5. Li GL, Fan CG, Bao Y, Jiang J, Li N, Li JS (2009) Neoadjuvant chemotherapy of FLEEOX regimen for unresectable gastric cancer resulting from advanced abdominal lymph nodes metastases. Zhonghua Wai Ke Za Zhi 47(15):1171–1174
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献